ArticleWorld journal of surgical oncology2025
Competing risk analysis for predicting distant metastasis in patients with upper urinary tract urothelial carcinoma following radical nephroureterectomy: based on a large dataset from a national medical center.
Article in World journal of surgical oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
Abstract
backgroundThe use of traditional Cox regression models to identify risk factors for distant metastasis (DM) after RNU (Radical nephroureterectomy) in UTUC (upper urinary tract urothelial carcinoma) patients may introduce bias. This study aims to utilize a large UTUC dataset from our center and apply the Fine-Gray model to determine predictive factors for DM. Additionally, we manage to construct a prediction model that can accurately estimate the likelihood of DM following RNU.
methodsA retrospective analysis was conducted on the clinical and pathological data of 2,546 patients with UTUC from Peking University First Hospital. Univariate and multivariate Fine-Gray competing risk models were employed to identify independent predictive factors for the occurrence of DM. Subsequently, a clinical nomogram was developed based on these factors. The predictive performance of the nomogram was rigorously evaluated using the C-index, receiver operating characteristic (ROC) curves, calibration curves, and decision curve analysis (DCA). Patients were stratified into two distinct risk categories according to their nomogram scores, the prognostic outcomes and potential treatment strategies for different risk groups were then compared and analyzed.
resultsOur study identified six independent predictors of DM: hydronephrosis, tumor dimensions, tumor architecture, surgical margin, pathological T stage, and N stage. A nomogram-based clinical model constructed using these predictors demonstrated excellent predictive performance, with C-indices of 0.781, 0.825, and 0.830 in the training set, validation set 1, and validation set 2, respectively. Additionally, the net benefit of this nomogram-based scoring system was superior to that of the AJCC model. High-risk populations identified using this scoring system may derive significant benefit from chemotherapy, potentially altering their prognostic outcomes.
conclusionsOur study identified independent risk factors for the development of DM following surgery in patients with UTUC. The clinical nomogram developed based on these factors demonstrates satisfactory predictive performance and holds significant clinical utility. This tool can assist clinicians in adjusting follow-up strategies and developing personalized treatment options for individual patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.